Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy
- PMID: 25590932
- PMCID: PMC4290743
- DOI: 10.5935/abc.20140164
Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy
Abstract
Background: Morbimortality in patients with dilated idiopathic cardiomyopathy is high, even under optimal medical treatment. Autologous infusion of bone marrow adult stem cells has shown promising preliminary results in these patients.
Objective: Determine the effectiveness of autologous transplantation of bone marrow adult stem cells on systolic and diastolic left ventricular function, and on the degree of mitral regurgitation in patients with dilated idiopathic cardiomyopathy in functional classes NYHA II and III.
Methods: We administered 4,54 x 10(8) ± 0,89 x 10(8) bone marrow adult stem cells into the coronary arteries of 24 patients with dilated idiopathic cardiomyopathy in functional classes NYHA II and III. Changes in functional class, systolic and diastolic left ventricular function and degree of mitral regurgitation were assessed after 3 months, 6 months and 1 year.
Results: During follow-up, six patients (25%) improved functional class and eight (33.3%) kept stable. Left ventricular ejection fraction improved 8.9%, 9.7% e 13.6%, after 3, 6 and 12 months (p = 0.024; 0.017 and 0.018), respectively. There were no significant changes neither in diastolic left ventricular function nor in mitral regurgitation degree. A combined cardiac resynchronization and implantable cardioversion defibrillation was implanted in two patients (8.3%). Four patients (16.6%) had sudden death and four patients died due to terminal cardiac failure. Average survival of these eight patients was 2.6 years.
Conclusion: Intracoronary infusion of bone marrow adult stem cells was associated with an improvement or stabilization of functional class and an improvement in left ventricular ejection fraction, suggesting the efficacy of this intervention. There were no significant changes neither in left ventricular diastolic function nor in the degree of mitral regurgitation.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures






Similar articles
-
[Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy].Rev Med Chil. 2015 Apr;143(4):415-23. doi: 10.4067/S0034-98872015000400001. Rev Med Chil. 2015. PMID: 26204531 Clinical Trial. Spanish.
-
Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.Eur J Cardiothorac Surg. 2009 Jun;35(6):995-1003; discussion 1003. doi: 10.1016/j.ejcts.2008.11.007. Epub 2009 Jan 10. Eur J Cardiothorac Surg. 2009. PMID: 19136274
-
A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.Circ Heart Fail. 2009 Sep;2(5):417-23. doi: 10.1161/CIRCHEARTFAILURE.109.855023. Epub 2009 Jul 29. Circ Heart Fail. 2009. PMID: 19808371 Clinical Trial.
-
The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.Heart Fail Rev. 2022 May;27(3):811-820. doi: 10.1007/s10741-021-10082-0. Epub 2021 Feb 15. Heart Fail Rev. 2022. PMID: 33587248 Review.
-
A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy.Stem Cell Res Ther. 2016 Dec 9;7(1):186. doi: 10.1186/s13287-016-0441-x. Stem Cell Res Ther. 2016. PMID: 27938412 Free PMC article.
References
-
- Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331(23):1564–1575. - PubMed
-
- Felker GM, Thompson RE, Hare JM, Hruban RA, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084. - PubMed
-
- The Criteria Committee of the New York Heart Association . Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Little, Brown & Co; 1994. pp. 253–256.
-
- Hunt SA, Abraham WT, Chin MH, Feldmann AM, Francis GS, Ganiats TG, et al. American College of Cardiology. American Heart Association Task Force on Practice Guidelines. American College of Chest Physicians. International Society for Heart and Lung Transplantation. Heart Rhythm Society ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–e235. - PubMed
-
- Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Pt 2Am Heart J. 1998;135(6) Su:S293–S309. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical